Is a Mass Immunization Program for Pandemic (H1N1) 2009 Good Value for Money? Early Evidence from the Canadian...

Area of Science:

• Public Health
• Health Economics
• Epidemiology

Background:

• The 2009 pandemic H1N1 influenza outbreak prompted mass immunization efforts.
• Evaluating the economic value of such public health interventions is crucial for policy decisions.

Purpose of the Study:

• To conduct a cost-utility analysis of the 2009 pandemic H1N1 mass immunization program in Ontario, Canada.
• To estimate the economic merits and health outcomes of the immunization program.

Main Methods:

• A simulation model of the pandemic H1N1 outbreak was developed.
• The analysis incorporated surveillance and administrative data from Ontario.
• Cost-utility analysis compared no immunization versus mass immunization (30% population coverage).

Main Results:

• The estimated cost for the Ontario immunization program was $118 million.
• The program was projected to reduce influenza cases by 50%.
• It was expected to prevent 35 deaths and halve treatment costs.

Conclusions:

• The 2009 pandemic H1N1 immunization program in Ontario is likely to be highly cost-effective.
• Mass immunization offers significant public health benefits and economic advantages.
• The findings contribute valuable data to the ongoing debate on pandemic immunization programs.